AstraZeneca Pharma India Limited — Board Meeting, 11-02-2025: Outcome of Board Meeting

At the recent board meeting, AstraZeneca Pharma India Limited approved the financial results for the quarter and nine months ended December 31, 2024. Key highlights include:

- Total revenue from operations stood at ₹4,402.9 Cr, a 44% increase compared to the same quarter last year.

- Profit before exceptional items and tax was ₹755.7 Cr.

- Profit after exceptional items was ₹308.5 Cr.

The board discussed the company's strategy aimed at enhancing market focus and operational excellence. Significant investments in research and partnerships were also reiterated to bolster growth in therapeutic areas, especially oncology and biopharmaceuticals.